[Improvement of cardiac glycoside therapy].
D000113:Acetyldigoxins / Q000627:therapeutic use*; D001682:Biological Availability; D002301:Cardiac Glycosides / Q000627:therapeutic use*; D003365:Costs and Cost Analysis; D004077:Digoxin / Q000031:analogs & derivatives*; D004304:Dosage Forms; D004361:Drug Tolerance; D004470:Economics, Medical; D004562:Electrocardiography; D007536:Isomerism
D000113:Acetyldigoxins; D002301:Cardiac Glycosides; D004304:Dosage Forms; D004077:Digoxin
Zur Optimierung der Therapie mit Herzglykosiden.